RecruitingNot Applicable

Alzheimer's Disease Genetics Study

United States10,000 participantsStarted 2002-06

Plain-language summary

The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Two living family members diagnosed with AD or other dementia with any age of onset * Biological samples available * Fresh blood, or * Immortalized lymphoblastic cell lines, or * 3-5 grams of frozen cerebral cortex; fixed samples are not accepted Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members. Exclusion Criteria: * Does not meet inclusion criteria * Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection

What they're measuring

Distribute biological specimens to qualified investigators for use in their research studies.

Timeframe: Contact investigators annually for an update on progress and publication status.

Trial details

NCT IDNCT00064870

SponsorIndiana University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-07

Contact for this trial

Study Coordinator

1-800-526-2839 alzstudy@iu.edu

View on ClinicalTrials.gov More Alzheimer Disease trials